Assessing phytotoxicity and tolerance levels of ZnO nanoparticles on Raphanus sativus: implications for widespread adoptions

• Pathirannahalage Sahan Samuditha,
• Nadeesh Madusanka Adassooriya and
• Nazeera Salim

Beilstein J. Nanotechnol. 2024, 15, 115–125, doi:10.3762/bjnano.15.11

• elevated accumulation of Zn [1][3]. Long-term, high-dose Zn supplementation disrupts copper intake, induces brain cell death, contributes to prostate cancer, and also functions as a gliotoxin and a neurotoxin [3][4]. Conversely, the most common micronutrient deficiency of crop plants is Zn deficiency

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• been applied to treat prostate cancer [56]. This nanoagent shows good drug-loading capacity and photosensitivity and can be applied in NIR photothermal conversion. After the autophagy inhibitor chloroquine (CQ) was loaded onto the nanocarrier, it was coated with prostate cancer cell membrane for tumor

Effects of substrate stiffness on the viscoelasticity and migration of prostate cancer cells examined by atomic force microscopy

• Xiaoqiong Tang,
• Yan Zhang,
• Jiangbing Mao,
• Yuhua Wang,
• Zhenghong Zhang,
• Zhengchao Wang and
• Hongqin Yang

Beilstein J. Nanotechnol. 2022, 13, 560–569, doi:10.3762/bjnano.13.47

• unclear how mechanical properties regulate the cellular response to the environmental matrix. In this study, atomic force microscopy (AFM) and laser confocal imaging were used to qualitatively evaluate the relationship between substrate stiffness and migration of prostate cancer (PCa) cells. Cells

• substrate stiffness and the mechanical properties of cells in prostate tumour metastasis, providing a basis for understanding the changes in the biomechanical properties at a single-cell level. Keywords: actin cytoskeleton; atomic force microscopy; migration; prostate cancer cells; substrate stiffness

• ; viscoelasticity; Introduction Prostate cancer is a common malignancy of the male urinary tract and has become the second most threatening type of cancer in male patients after lung cancer [1][2]. Clinical data indicate that 90% of patients have a survival rate of more than 10 years if the prostate tumour is

Use of nanosystems to improve the anticancer effects of curcumin

• Andrea M. Araya-Sibaja,
• Norma J. Salazar-López,
• Krissia Wilhelm Romero,
• José R. Vega-Baudrit,
• J. Abraham Domínguez-Avila,
• Carlos A. Velázquez Contreras,
• Ramón E. Robles-Zepeda,
• Mirtha Navarro-Hoyos and
• Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

• molecular targeting properties [40]. An LPHN was co-loaded with CUR and with docetaxel (82% and 90% average EE, respectively) and assayed in mice bearing PC3 (human prostate cancer) tumor xenografts [87]. The results showed higher cytotoxicity and a synergistic effect, which resulted in tumor growth

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

• . reported that when the distance between the cell and the MB was increased to 5.5 µm, the exerted shear stress on the cell membrane suddenly decreased [78]. Schlicher et al. exposed prostate cancer cells (DU145) to 24 kHz US irradiation to investigate the cavitation events and the changes in the cell

• isothiocyanate (FITC)-labeled bovine serum albumin (BSA), FITC-labeled 150, 500, and 2000 kDa dextrans into DU145 prostate cancer cells. They blocked the endocytosis mechanism to assess whether the endocytic pathway was upregulated during US exposure. They showed that all of these fluorescent molecules were

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

• Nikola Geskovski,
• Nadica Matevska-Geshkovska,
• Simona Dimchevska Sazdovska,
• Marija Glavas Dodov,
• Kristina Mladenovska and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy

• Gayathri Kandasamy,
• Elena N. Danilovtseva,
• Vadim V. Annenkov and
• Uma Maheswari Krishnan

Beilstein J. Nanotechnol. 2020, 11, 354–369, doi:10.3762/bjnano.11.26

• –imidazole polyamide system was found to inhibit prostate cancer progression through interfering with the expression and function of the androgen receptor [13]. Chitosan–imidazole derivatives have been also explored for gene transfection in HEK293 cells [14]. In recent years, poly(vinylimidazole)-based

Advanced hybrid nanomaterials

• Andreas Taubert,
• Fabrice Leroux,
• Pierre Rabu and
• Verónica de Zea Bermudez

Beilstein J. Nanotechnol. 2019, 10, 2563–2567, doi:10.3762/bjnano.10.247

• nanoparticles [34]. The resulting gold–alendronate nanoplatform combines antitumor activity through drug delivery and photothermal therapy, as illustrated in vitro on the inhibition of prostate cancer cells. In the field of hybrid coordination networks, new lanthanide-based networks synthesized by a solvo

pH-Controlled fluorescence switching in water-dispersed polymer brushes grafted to modified boron nitride nanotubes for cellular imaging

• Saban Kalay,
• Yurij Stetsyshyn,
• Volodymyr Donchak,
• Khrystyna Harhay,
• Ostap Lishchynskyi,
• Halyna Ohar,
• Yuriy Panchenko,
• Stanislav Voronov and
• Mustafa Çulha

Beilstein J. Nanotechnol. 2019, 10, 2428–2439, doi:10.3762/bjnano.10.233

• contrast to acidic pH conditions where the fluorescent intensity is absent or low. No increase in the absorption was observed when the suspension pH was increased from 7 to 10. The functionalized BNNTs are easily taken up by human normal prostate epithelium (PNT1A) and human prostate cancer cell lines

• obtained with a Carl Zeiss Evo-40 instrument under high vacuum and accelerating voltage of 10 kV. Cell culture experiments Normal prostate epithelium (PNT1A) and human prostate cancer (DU145) cell lines were grown in Dulbecco’s Modified Eagle’s Medium, supplemented with 10% fetal bovine serum and 1

• uptake of P(AA-co-FA)-functionalized BNNTs into human normal prostate epithelium (PNT1A) and human prostate cancer (DU145) cell lines, we used fluorescence microscopy with excitation at 490 nm and emission at 520 nm (Figure 9). The autofluorescence of healthy cells and cancer cells was strictly avoided

Use of data processing for rapid detection of the prostate-specific antigen biomarker using immunomagnetic sandwich-type sensors

• Camila A. Proença,
• Tayane A. Freitas,
• Thaísa A. Baldo,
• Elsa M. Materón,
• Flávio M. Shimizu,
• Gabriella R. Ferreira,
• Frederico L. F. Soares,
• Ronaldo C. Faria and
• Osvaldo N. Oliveira Jr.

Beilstein J. Nanotechnol. 2019, 10, 2171–2181, doi:10.3762/bjnano.10.210

• ; nanoarchitectonics; information visualization; sandwich-type immunosensors; screen-printed electrodes; Introduction The prostate-specific antigen (PSA) used in clinical diagnosis is present in normal prostatic secretions, but its concentration is often elevated in prostate cancer patients. In spite of its lack of

• specificity, PSA screening has contributed to a significant decline (45–70%) in prostate cancer mortality since the early 1990s [1]. To identify cancer biomarkers and to develop methodologies to quantify them at low cost is critical for early cancer diagnostics, while it also helps to understand cancer

• carbon electrodes (INμ-SPCEs) showed limits of detection of 0.23 pg·mL−1 for PSA and 0.30 pg·mL−1 for IL-6, measured in the serum of prostate cancer patients [26]. Immunosensors to detect PSA include magnetic nanoparticles modified with gold [27], nitrodopamine functionalized iron oxide nanoparticles [3

Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells

• Liang Xu,
• Dekang Xu,
• Ziying Li,
• Yu Gao and
• Haijun Chen

Beilstein J. Nanotechnol. 2019, 10, 1933–1942, doi:10.3762/bjnano.10.189

• anticancer activities, such as restraining the hTERT gene expression in A549 lung cancer cells [3], inhibiting breast cancer stem-like cells via Wnt β-catenin signaling [4], impeding hepatocellular carcinoma cells by increasing DDX3 expression [5], and inducing apoptosis of prostate cancer cells through

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• efficient in vitro treatment of human prostate cancer cells. The excellent performance could be explained by the multivalence effect. The fact of having the same ligand interacting with the same receptor simultaneously without any other non-specific interaction from the other ligand maximized the

Hybrid Au@alendronate nanoparticles as dual chemo-photothermal agent for combined cancer treatment

• Anouchka Plan Sangnier,
• Romain Aufaure,
• Laurence Motte,
• Claire Wilhelm,
• Erwann Guenin and
• Yoann Lalatonne

Beilstein J. Nanotechnol. 2018, 9, 2947–2952, doi:10.3762/bjnano.9.273

• under irradiation within the first biological window (650–900 nm). The Au@alendronate nanoplatform thus provided a combined antitumor activity through drug delivery and photothermal therapy. Au@alendronate NPs inhibited in vitro the proliferation of prostate cancer cells (PC3) in a dose-dependent manner

Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

• Cem Varan and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1446–1456, doi:10.3762/bjnano.8.144

• effective on growth inhibition of breast and prostate cancer cells when compared to free docetaxel [23]. Core–shell nanoparticles are also used as non-viral vectors for the treatment of glioma. Zamora et al. prepared photochemical internalization mediated polyamine core–shell nanoparticles for tumor

Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation

• Kati Erdmann,
• Jessica Ringel,
• Silke Hampel,
• Manfred P. Wirth and
• Susanne Fuessel

Beilstein J. Nanotechnol. 2017, 8, 1307–1317, doi:10.3762/bjnano.8.132

• , Dresden 01171, Germany 10.3762/bjnano.8.132 Abstract We have previously shown that carbon nanofibers (CNFs) and carbon nanotubes (CNTs) can sensitize prostate cancer (PCa) cells to platinum-based chemotherapeutics. In order to further verify this concept and to avoid a bias, the present study

• . Co-administration of chemotherapeutics with carbon nanomaterials could result in a reduction of the chemotherapeutic dosage and thus limit systemic side effects. Keywords: carbon nanomaterials; chemosensitization; docetaxel; mitomycin C; prostate cancer cells; Introduction According to the global

• cancer statistics, prostate cancer (PCa) is the second most often diagnosed cancer in males worldwide and it ranks in fifth place among cancer-related deaths [1]. Localized PCa is usually treated by surgical removal of the prostate (radical prostatectomy) or by radiation therapy. Both treatment options

Nano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot delivery

• Liga Saulite,
• Dominyka Dapkute,
• Karlis Pleiko,
• Ineta Popena,
• Simona Steponkiene,
• Ricardas Rotomskis and
• Una Riekstina

Beilstein J. Nanotechnol. 2017, 8, 1218–1230, doi:10.3762/bjnano.8.123

• therapeutic nano-agents [24]. Studies on melanoma [25], prostate cancer [26], breast cancer [6] and lung cancer [27] have shown the ability of MSCs to home to cancer sites in vivo. In the tumour microenvironment, MSCs play a role in the formation of the tumour stroma and support cancer metastasis [28

Phospholipid arrays on porous polymer coatings generated by micro-contact spotting

• Sylwia Sekula-Neuner,
• Monica de Freitas,
• Lea-Marie Tröster,
• Tobias Jochum,
• Pavel A. Levkin,
• Michael Hirtz and
• Harald Fuchs

Beilstein J. Nanotechnol. 2017, 8, 715–722, doi:10.3762/bjnano.8.75

• of prostate cancer [19]. AR contributes to breast cancer progression and development [20] and its mutation is involved in the progression of neurodegenerative diseases, such as the X-linked spinal and bulbar muscular atrophy [21]. In order to better understand and characterize the behavior and

• the therapeutic treatment for breast and prostate cancer patients. Keeping in mind previous applications of HEMA polymer in creating superhydrophilic–superhydrophobic micropatterned surfaces for cell patterning [28] and cell-screening applications [29][30], the addition of lipid arraying to the

Association of aescin with β- and γ-cyclodextrins studied by DFT calculations and spectroscopic methods

• Ana I. Ramos,
• Pedro D. Vaz,
• Susana S. Braga and
• Artur M. S. Silva

Beilstein J. Nanotechnol. 2017, 8, 348–357, doi:10.3762/bjnano.8.37

• ]. In vitro incubation with cells of the C6 (glioma) and A549 (lung adenocarcinoma) tumoural lines showed that aescin has potent dose- and time-dependent antiproliferative effects [8]. Studies with human castration-resistant prostate cancer, both in vitro, using the cell lines PC-3 and DU-145, and in

Multiwalled carbon nanotube hybrids as MRI contrast agents

• Nikodem Kuźnik and
• Mateusz M. Tomczyk

Beilstein J. Nanotechnol. 2016, 7, 1086–1103, doi:10.3762/bjnano.7.102

• period, is consistent with the abovementioned toxicity studies. Cytotoxicity and hemolysis Cytotoxicity of the nanohybrids was studied on various cell types (HeLa, HEK 293, human prostate cancer cells PC3, fibroblasts and others) and a general conclusion is the dose-dependent trend. However, the

Using natural language processing techniques to inform research on nanotechnology

• Nastassja A. Lewinski and
• Bridget T. McInnes

Beilstein J. Nanotechnol. 2015, 6, 1439–1449, doi:10.3762/bjnano.6.149

• ][27]. More recently, the research group expanded the scope to include applications of carbon nanotubes such as incorporation in photovoltaic cells and prostate cancer therapeutics [28]. The patents, which spanned the years 1992 to 2009, were collected from E.U., Japan, Korea and U.S. patent databases

Overview about the localization of nanoparticles in tissue and cellular context by different imaging techniques

• Anja Ostrowski,
• Daniel Nordmeyer,
• Alexander Boreham,
• Cornelia Holzhausen,
• Lars Mundhenk,
• Christina Graf,
• Martina C. Meinke,
• Annika Vogt,
• Sabrina Hadam,
• Jürgen Lademann,
• Eckart Rühl,
• Ulrike Alexiev and
• Achim D. Gruber

Beilstein J. Nanotechnol. 2015, 6, 263–280, doi:10.3762/bjnano.6.25

• deposits in HE-stained sections of glioblastomas (Figure 1a), a common brain tumor with high clinical relevance [45]. Such particles have similarly been visualized after targeting prostate cancer cells in humans [46]. Iron oxide nanoparticles have been introduced as diagnostic tool or for the treatment of

Increasing throughput of AFM-based single cell adhesion measurements through multisubstrate surfaces

• Miao Yu,
• Nico Strohmeyer,
• Jinghe Wang,
• Daniel J. Müller and
• Jonne Helenius

Beilstein J. Nanotechnol. 2015, 6, 157–166, doi:10.3762/bjnano.6.15

• limitation, segmented polydimethylsiloxane (PDMS) masks were developed, allowing the measurement of cell adhesion to multiple substrates. To verify the utility of the masks, the adhesion of four different cell lines, HeLa (Kyoto), prostate cancer (PC), mouse kidney fibroblast and MDCK, to three extracellular

Synthesis of boron nitride nanotubes and their applications

• Saban Kalay,
• Zehra Yilmaz,
• Ozlem Sen,
• Melis Emanet,
• Emine Kazanc and
• Mustafa Çulha

Beilstein J. Nanotechnol. 2015, 6, 84–102, doi:10.3762/bjnano.6.9

• composites in the presence and absence of a magnetic field [84]. The BNNT–NaGdF4:Eu composites simultaneously show fluorescent and magnetic properties. Thus, imaging and targeting of the composites can be more easily achieved. Human LNCaP prostate cancer cells were treated with the BNNT–NaGdF4:Eu composites

• in the presence and absence of a magnetic field and higher cell-associated uptake was found in the presence of a magnetic field. Then, the composites were loaded with doxorubicin (dox) to investigate the viability of LNCaP prostate cancer cells in the magnetic field. It was found that dox-loaded BNNT

• pH dependent and both negatively and positively charged structures had the same dox loading capacity. The BNNT–MS–NH2 had higher uptake potential in LNCaP prostate cancer cells due to its charge. Thus, it had a higher toxicity towards LNCaP prostate cancer cells. It was concluded that the prepared

Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer

• Amanee D Salaam,
• Patrick Hwang,
• Roberus McIntosh,
• Hadiyah N Green,
• Ho-Wook Jun and
• Derrick Dean

Beilstein J. Nanotechnol. 2014, 5, 937–945, doi:10.3762/bjnano.5.107

• delivery system for bone metastatic prostate cancer was developed, characterized, and evaluated in vitro. NDs were conjugated with the Asp–Gly–Glu–Ala (DGEA) peptide to target α2β1 integrins over-expressed in prostate cancers during metastasis. To facilitate drug delivery, DOX was adsorbed to the surface

• ; doxorubicin; nanodiamond; prostate cancer; targeted drug delivery; Introduction Prostate cancer is the most frequently diagnosed malignancy in men [1]. Typically the disease is slow growing, but in some cases it progresses to an aggressively metastatic state. When prostate cancer becomes metastatic, the

• current standard of care is chemotherapy, which involves the use of toxic anticancer drugs, like doxorubicin (DOX), to treat cancers by inducing apoptosis. DOX has had high success rates with treating prostate cancer [2]. However, it can cause major side effects such as hair loss, nausea [2][3], and